デジタルセラピューティクス(DTx):新時代の医学

出版:BCC Research(BCCリサーチ) 出版年月:2022年11月

Digital Therapeutics: A New Age Medicine
デジタルセラピューティクス(DTx):新時代の医学

ページ数 61
価格
 シングルユーザライセンス USD 3,500
 2-5ユーザライセンス USD 4,200
 サイトライセンス USD 5,040
 エンタープライズライセンス USD 6,048
種別 英文調査報告書

レポート目次  お問合せ・ご注文  価格・納期について

無料サンプル

Report Highlights

The goal of this report is to understand the current digital therapeutics scenario and to assess the market’s growth potential. This study explores market dynamics that impact the growth of the market. The main objective of the study is to present a comprehensive analysis of the current market and the future direction of the market.

Summary:

Digital therapeutics (DTx) is considered a subset of digital health. These are evidence-based, innovative interventions in which the therapeutic activity is based on algorithms and software. These interventions can be a standalone treatment or used in combination with the current medications.

Digital therapeutics are highly customizable tools and hence the growing demand for personalized and preventive treatment will be a driving factor for the market. The tool allows better involvement of the patient in the management of the disease. Thus, this technology provides an opportunity to cater to the chronic diseases segment.

Chronic diseases create a significant burden on the healthcare system in terms of morbidity and finances. Since the majority are lifestyle-related disorders, modifications in lifestyle will help to prevent or reduce the burden of the diseases. An example of this is prediabetes prevention, where DTx tools will help to prevent or delay the diagnosis of the disease. DTx also provides digital cognitive behavioral therapies (CBT), which are required for psychiatric indications such as post-traumatic stress disorder (PTSD), attention-deficit/hyperactivity disorder (ADHD), and depression. Due to the pandemic, the prevalence of these psychiatric disorders has also increased. Thus, the increasing prevalence of chronic
conditions and the increasing burden of the healthcare system will lead to increased adoption of digital solutions. Compared to traditional drug development, the cost of developing digital therapeutics is relatively low.

The other factors contributing to the growth of the market include increasing investment in digital health and digital therapeutics, growing research activities, and the increasing use of smartphones, mhealth apps, and wearables. It is observed that initially only academic and tech companies were involved in the development and research of digital therapeutics. But the increasing investments in this space have attracted a number of pharma and other players in the market. The market has a number of small players and start-up companies and is expected to witness the entry of other players in the future, as many companies have ongoing pivotal trials in their portfolio.

Since this market is in its nascent stage, there is a lack of regulatory and reimbursement guidelines. Hence, developing proper regulatory and reimbursement frameworks will attract more users to the market.

In this report, the market is segmented based on application, sales channel, and region. The North American market currently holds the highest market share, followed by Europe. This leadership role is due to the increasing prevalence of chronic diseases in the U.S., increasing investments, rising demand for cost-effective and patient-centric solutions, and increasing awareness.

Report Scope:

The current report covers the booming technology of digital therapeutics. It also investigates the current shift in trends away from conventional methods of treatment toward the advanced means offered by digital therapeutics. This report is an update of an earlier report of the same title but focuses on more in-depth information. This report offers a comprehensive analysis of the global digital therapeutics market. Segmentation is based on application and sales channels. Based on application, the market is segmented as diabetes, psychiatric and addiction, neurological, cardiovascular diseases, and others. Based on sales channel the market is segmented as business-to-consumer (B2C) and business-to-business (B2B). The regional markets covered are North America, Europe, Asia-Pacific, and the Rest of the World (RoW). For market estimates, data has been provided for 2019, 2020, and 2021 as the base year, 2022, and a forecast for 2027.

The report provides a detailed overview and analysis of the present and future global market for digital therapeutics. Industry growth drivers, restraints, and opportunities are also discussed in detail. The report also provides a competitive landscape, elaborative company profiles, and the impact of COVID-19 on the market. The report focuses on the companies that are developing and encouraging digital therapeutics technology and doing research to develop the technology further.

Report Includes:

– A brief general outlook of the global market for digital therapeutics scenario
– Analyses of the global market trends, with market revenue data from 2019 to 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
– Highlights of the current and upcoming market potential for digital therapeutics, and areas of focus to forecast this market into various segments and subsegments
– Updated information on market opportunities and drivers, key shifts and trends, regulations and industry specific challenges, and other factors that will shape this market demand in the coming years (2022-2027)
– Identification of the companies best positioned to meet the demand owing to their proprietary technologies, product launches, mergers and acquisitions, and other market strategic advantages
– Review of the technology landscape for digital therapeutics marketplace with emphasis on recently approved products as well as products under development or in different stages of clinical trials
– Profile descriptions of the market leading participants, including Big Health, Happify, Omada Health Inc., Pear Therapeutics and Welldoc


目次

Table of Contents
Chapter 1 Market Outlook
1.1 Market Snapshot
Chapter 2 Summary and Highlights
Chapter 3 Market Overview
3.1 Overview
3.2 Evolution of Digital Therapeutics
3.3 Regulatory Framework
3.4 Reimbursement
3.5 Benefits of Digital Therapeutics
3.6 Digital Therapeutics Ecosystem
Chapter 4 Market Dynamics
4.1 Factors Affecting the Digital Therapeutics Market
4.2 Market Drivers
4.2.1 Increasing Incidence of Chronic Diseases
4.2.2 Increasing Investments
4.2.3 Increasing Preventive Healthcare
4.2.4 Cost-Effective
4.2.5 Rising Use of mHealth Apps and Wearables
4.3 Market Restraints
4.3.1 Physician Adoption
4.3.2 Data Privacy and Security Concerns
4.3.3 Regulatory Approval
4.3.4 Reimbursement
4.4 Opportunities
4.4.1 Growing Technology Innovations
4.5 Impact of COVID-19
Chapter 5 Digital Therapeutics Market by Application
5.1 Global Digital Therapeutics Market by Application
5.2 Diabetes
5.3 Psychiatric Conditions and Addictions
5.4 Cardiovascular Diseases
5.5 Neurological Diseases
5.6 Other Diseases
Chapter 6 Digital Therapeutics Market by Sales Channel
6.1 Business-to-Business (B2B)
6.2 Business-to-Consumer (B2C)
Chapter 7 Digital Therapeutics Market by Region
7.1 North America
7.2 Europe
7.3 Asia-Pacific
7.4 Rest of the World
Chapter 8 Competitive Landscape and Analysis of Market Opportunities
8.1 Strategic Initiatives
8.2 Competitive Analysis
Chapter 9 Company Profiles
AKILI INTERACTIVE LABS INC.
BIG HEALTH
CLICK THERAPEUTICS
HAPPIFY
OMADA HEALTH INC.
OREXO AB
PEAR THERAPEUTICS
PROPELLER HEALTH
VOLUNTIS
WELLDOC
Chapter 10 Project Scope and Methodology
10.1 Study Goals and Objectives
10.2 Reasons for Doing This Study
10.3 Scope of Report
10.4 What’s New in This Update?
10.5 Information Sources
10.6 Methodology
10.7 Geographic Breakdown
10.8 Analyst’s Credentials
10.9 BCC Custom Research
10.10 Related BCC Research Reports

List of Tables
Summary Table A : Global Digital Therapeutics Market, Through 2027
Table 1 : Examples of Products of Digital Health, Medicine, and Therapeutics
Table 2 : Digital Therapeutics Products
Table 3 : Digital Health Apps Globally, 2015-2021
Table 4 : Global Market for Digital Therapeutics, Through 2027
Table 5 : Global Digital Therapeutics Market, by Application, Through 2027
Table 6 : Global Digital Therapeutics Market for Diabetes, by Region, Through 2027
Table 7 : Global Digital Therapeutics Market for Psychiatric Conditions and Addictions, by Region, Through 2027
Table 8 : Global Digital Therapeutics Market for Cardiovascular Diseases, by Region, Through 2027
Table 9 : Global Digital Therapeutics Market for Neurological Diseases, by Region, Through 2027
Table 10 : Global Digital Therapeutics Market for Other Diseases, by Region, Through 2027
Table 11 : Global Digital Therapeutics Market, by Sales Channel, Through 2027
Table 12 : Global Digital Therapeutics Market for B2B Sales Channel, by Region, Through 2027
Table 13 : Global Digital Therapeutics Market for B2C Sales Channel, by Region, Through 2027
Table 14 : Global Digital Therapeutics Market, by Region, Through 2027
Table 15 : Mergers and Acquisitions, 2020-2022

List of Figures
Summary Figure A : Global Digital Therapeutics Market, 2019-2027
Figure 1 : Differences between Digital Health, Digital Medicine, and Digital Therapeutics
Figure 2 : Digital Therapeutics Composition
Figure 3 : Digital Therapeutics: Key Milestones
Figure 4 : Digital Therapeutics: Stakeholders Benefits
Figure 5 : Global Digital Therapeutics Market, by Application, 2019-2027
Figure 6 : Global Digital Therapeutics Market Shares, by Application, 2021
Figure 7 : Global Incidence of People Living with Diabetes Aged 20-79 Years, by Region, 2021, 2030, and 2045
Figure 8 : Global Digital Therapeutics Market for Diabetes, by Region, 2019-2027
Figure 9 : Global Digital Therapeutics Market for Psychiatric Conditions and Addictions, by Region, 2019-2027
Figure 10 : Share of Heart Disease Deaths in the U.S., by Disease Type, 2021
Figure 11 : Global Digital Therapeutics Market for Cardiovascular Diseases, by Region, 2019-2027
Figure 12 : Global Digital Therapeutics Market for Neurological Diseases, by Region, 2019-2027
Figure 13 : Global Digital Therapeutics Market for Other Diseases, by Region, 2019-2027
Figure 14 : Global Digital Therapeutics Market, by Sales Channel, 2019-2027
Figure 15 : Global Digital Therapeutics Market for B2B Sales Channel, by Region, 2019-2027
Figure 16 : Global Digital Therapeutics Market for B2C Sales Channel, by Region, 2019-2027
Figure 17 : Global Digital Therapeutics Market, by Region, 2019-2027
Figure 18 : Global Digital Therapeutics Market Shares, by Region, 2021
Figure 19 : Global Digital Therapeutics Market Shares, 2021
Figure 20 : Orexo: Annual Revenue, 2019-2021
Figure 21 : Pear Therapeutics: Annual Revenue, 2020 and 2021


    お問合せフォーム

    • レポートのタイトルは自動で入ります。
    • *のある項目は必須項目です。

    お名前*

    会社名*

    部署名

    メールアドレス*

    電話番号

    当ウェブサイトを知った経緯を教えてください。

    お問合せ内容

    株式会社SEMABIZ・ChosaReport.com プライバシーポリシー

    Eメールでのお問合せもお受けしております。
    下記アドレスへ“(at)”を“@”に変えてお送りください。通常1営業日以内にご返信いたします。
    crinquiry(at)chosareport.com